Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ilex Oncology initiates phase III trial of DFMO

Feb. 25, 1999

New Lilly SERMs especially useful for breast cancer

Feb. 25, 1999

NCI to conduct phase III trial of pure shark cartilage

Feb. 24, 1999

Orphan Medical launches improved form of busulfan in U.S.

Feb. 24, 1999

U.S. patent extends coverage for Immune Response's TCR vaccine technology

Feb. 24, 1999

Immunomedics and NCI to study new class of anticancer agents

Feb. 24, 1999

NeoPharm and Pharmacia & Upjohn reach licensing agreement for liposomal cancer formulations

Feb. 24, 1999

Activity of novel deoxyadenosine analogue investigated against human colon tumors

Feb. 23, 1999

Antiproliferative agents from Warner-Lambert act by inhibiting MEK kinase

Feb. 23, 1999

U.S. patent covers fundamental basis of Prolifix's R&D program

Feb. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...